Search

Author/Creator Callendret, Benoit

1. Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years. (22nd April 2020)

Authors:
Williams, Kristi; Bastian, Arangassery Rosemary; Feldman, Robert Allen; Omoruyi, Edmund; de Paepe, Els; Hendriks, Jenny; van Zeeburg, Hester; Godeaux, Olivier; Langedijk, Johannes P M; Schuitemaker, Hanneke; Sadoff, Jerry; Callendret, Benoit
Journal:
Journal of infectious diseases
Issue:
Volume 222:Number 6(2020)
Page Start:
979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study. (4th December 2021)

Authors:
Falsey, Ann R; Williams, Kristi; Gymnopoulou, Efi; Bart, Stephan A; Ervin, John E; Bastian, Arangassery Rosemary; Menten, Joris; De Paepe, Els; de Boer, Hilde; Vandenberghe, Sjoukje; Chan, Eric; Sadoff, Jerald; Douoguih, Macaya; Callendret, Benoit; Comeaux, Christy; Heijnen, Esther
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S812
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial. Issue 1 (January 2022)

Authors:
Ishola, David; Manno, Daniela; Afolabi, Muhammed O; Keshinro, Babajide; Bockstal, Viki; Rogers, Baimba; Owusu-Kyei, Kwabena; Serry-Bangura, Alimamy; Swaray, Ibrahim; Lowe, Brett; Kowuor, Dickens; Baiden, Frank; Mooney, Thomas; Smout, Elizabeth; Köhn, Brian; Otieno, Godfrey T; Jusu, Morrison; Fost...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 1(2022)
Page Start:
97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial. Issue 1 (January 2022)

Authors:
Afolabi, Muhammed O; Ishola, David; Manno, Daniela; Keshinro, Babajide; Bockstal, Viki; Rogers, Baimba; Owusu-Kyei, Kwabena; Serry-Bangura, Alimamy; Swaray, Ibrahim; Lowe, Brett; Kowuor, Dickens; Baiden, Frank; Mooney, Thomas; Smout, Elizabeth; Köhn, Brian; Otieno, Godfrey T; Jusu, Morrison; Fost...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 1(2022)
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models. Issue 6 (7th February 2022)

Authors:
Saeland, Eirikur; van der Fits, Leslie; Bolder, Renske; Heemskerk-van der Meer, Marjolein; Drijver, Joke; van Polanen, Yolinda; Vaneman, Cornelis; Tettero, Lisanne; Serroyen, Jan; Schuitemaker, Hanneke; Callendret, Benoit; Langedijk, Johannes P.M.; Zahn, Roland C.
Journal:
Vaccine
Issue:
Volume 40:Issue 6(2022)
Page Start:
934
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study. (16th September 2020)

Authors:
Goldstein, Neil; Bockstal, Viki; Bart, Stephan; Luhn, Kerstin; Robinson, Cynthia; Gaddah, Auguste; Callendret, Benoit; Douoguih, Macaya
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 4(2022)
Page Start:
595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study. (5th January 2021)

Authors:
Sadoff, Jerald; De Paepe, Els; DeVincenzo, John; Gymnopoulou, Efi; Menten, Joris; Murray, Bryan; Rosemary Bastian, Arangassery; Vandebosch, An; Haazen, Wouter; Noulin, Nicolas; Comeaux, Christy; Heijnen, Esther; Eze, Kingsley; Gilbert, Anthony; Lambkin-Williams, Rob; Schuitemaker, Hanneke; Callen...
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 3(2022)
Page Start:
396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct‐acting antiviral. Issue 5 (18th December 2015)

Authors:
Callendret, Benoit; Eccleston, Heather B.; Satterfield, William; Capone, Stefania; Folgori, Antonella; Cortese, Riccardo; Nicosia, Alfredo; Walker, Christopher M.
Journal:
Hepatology
Issue:
Volume 63:Issue 5(2016:May)
Page Start:
1442
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021)

Authors:
Pollard, Andrew J; Launay, Odile; Lelievre, Jean-Daniel; Lacabaratz, Christine; Grande, Sophie; Goldstein, Neil; Robinson, Cynthia; Gaddah, Auguste; Bockstal, Viki; Wiedemann, Aurelie; Leyssen, Maarten; Luhn, Kerstin; Richert, Laura; Bétard, Christine; Gibani, Malick M; Clutterbuck, Elizabeth A; ...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 4(2021)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗